-
Need to address issues in vaccination drive on an urgent basis
Vaccination is our only potent policy weapon which can bring an end to the present pandemic and its resultant economic crisis
-
COVID-19 Vaccination: Overcoming the fear of the needle
At a time when the virus is making a virulent comeback, India’s best possible response is in mass vaccination.
-
Double mutation of Covid-19 strain not necessarily a cause of concern: ICMR
The coronavirus-causing virus may be mutating, but its strategy of transmission remains the same; following Covid-protocols of prevention are still th
-
Need to change Covaxin composition not felt yet due to good efficacy against mutant variants: Centre
There are four mutations of the COVID-19 virus in India at present—two UK variants and one South African and Brazilian variant each
-
AstraZeneca reassures safety of COVID-19 vaccine; says no evidence of increased risks
The AstraZeneca/Oxford COVID-19 vaccine, which is being produced by Serum Institute of India, is part of the COVID-19 vaccination drive in India
-
Bharat Biotech’s Covaxin out of ‘clinical trial’ mode
Covaxin has now been granted the restricted emergency use authorisation
